申请人:Merck Sharp & Dohme Ltd.
公开号:US06500828B1
公开(公告)日:2002-12-31
1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing a difluoro-or tri-fluoro-substituted phenyl ring at the 3-position, a triazolyl moiety at the 6-position, and a tert-butyl group at the 7-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, and are useful in the treatment of anxiety and convulsions.
1,2,4-三唑[4,3-b]吡啶衍生物,在3位具有二氟或三氟取代的苯环,6位具有三唑基团,7位具有叔丁基基团,是GABAA受体的选择性配体,特别是具有高亲和力的&agr;2和/或&agr;3亚单位,可用于治疗焦虑和抽搐。